Healthcare Global Enterprises Ltd. · NSE:HCG
Healthcare Global Enterprises — Q2 & H1 FY26 Earnings Presentation
20 slides from Healthcare Global Enterprises's earnings presentation, Nov 12, 2025
Slide 1: Cover letter to stock exchanges: Investor Presentation
November 12, 2025 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam,
Slide 2: Q2 & H1 FY26 Results Presentation
HEALTHCARE GLOBAL ENTERPRISES LIMITED Q 2 & H1 F Y2 6 R e s u l ts P r e s e n t ati on November 12, 2025
Slide 3: Safe Harbor
SAFE HARBOR This presentation and its contents are confidential and are not for release, publication or distribution, in whole or in part, directly or indirectly, in or into or from the United States of America, Canada, Australia, Japan or any jurisdiction where such distribution is unlawful. This p
Slide 4: Company Overview
Company Overview 3 www.hcgoncology.com www. h c g o n c o l o g y. c o m
Slide 5: Largest Pan-India Oncology Hospital Chain
Largest Pan-India Oncology Hospital Chain LARGEST GEOGRAPHICAL REACH… 2 Center of Excellence (CoE) 10 19 ~55% 22 Cancer Care Centers 1 Number of Number of Addressable market3 4* Multi-specialty hospitals states covered5 cities covered5 (population) 6 Day care centers 25 16/18 3.7L+ Jaipur No. of cen
Slide 6: Q2 & H1 FY26 Financial & Operational Highlights
Q2 &H1 FY26 FINANCIAL & SUBASENI LENKA, CANCER WINNER OPERATIONAL HIGHLIGHTS I am eternally thankful to Dr. Panda and other specialists at HCG Panda Cancer Hospital, as the specialists were able to treat my condition the right way, the first time 5 www.hcgoncology.com www. h c g o n c o l o g y. c o
Slide 7: Financial Highlights Q2FY26
Financial Highlights Q2FY26 Rs in M n REVENUE R E V E N U E - H C G C e n t e r s (1) REVENUE - Milann Centers +16.9% +17.6% -6.2% 6,470 6,322 5,535 5,378 158 148 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Adjusted EBITDA PROFIT AFTER TAX PROFIT AFTER TAX Adjusted EBITDA * MARGIN * (Pre-IND AS) (Post
Slide 8: Financial Highlights H1FY26
Financial Highlights H1FY26 Rs in M n REVENUE R E V E N U E - H C G C e n t e r s (1) REVENUE - Milann Centers +16.8% +17.3% -1.5% 12,601 12,304 10,791 10,490 301 297 H1FY25 H1FY26 H1FY25 H1FY26 H1FY25 H1FY26 Adjusted EBITDA PROFIT AFTER TAX PROFIT AFTER TAX Adjusted EBITDA * MARGIN * (Pre-IND AS) (
Slide 9: Improved Performance Leading to Profitability
Improved Performance Leading to Profitability 1.6x 6,132 6,470 5,535 5,586 5,852 4,946 5,256 4,607 4,870 4,699 4,079 4,200 4,247 4,422 Revenue (INR mn) Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 1.7x 1,233 1,042 1,070 1,118 864 941 929 923 Adjusted 740 760 77
Slide 10: Growth Across HCG Centers
Growth Across HCG Centers Established Centers Emerging Centers ~1.3x g r o w t h i n l a s t 9 q u a r t e r s ~1.6x g r o w t h i n l a s t 9 q u a r t e r s REVENUE +17.5% +18.3% 5,396 5,695 587 587 627 4,848 4,931 5,264 530 519 4,290 4,330 4,637 475 4,117 403 417 446 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q
Slide 11: Strong Operating Metrics with Significant Capacity Headroom
Strong Operating Metrics with Significant Capacity Headroom Key Driver Metric Indicator % Revenue Q2’25 Q2’26 H1’25 H1’26 +23% +22% 134 263 Lead indicator of Volume Growth; key 109 215 OPD Footfall (‘000) operating metric tracked by HCG; has 18%* correlation to OPD Footfalls +24% +22% 54 103 43 84 C
Slide 12: HCG – Q2FY26 Operational Metrics
HCG – Q2FY26 Operational Metrics # TOTAL AOR (%) ESTABLISHED CENTERS AOR (%) EMERGING CENTERS AOR^* (%) Operational beds increased 70.3% 71.4% 56.7% from 1,932 in Q2FY25 to 2,189 in Q2FY26. On a like 67.2% in Q2FY25 68.8% in Q2FY25 48.6% in Q2FY25 to like basis, total AOR 312 bps stands at 76% 260 b
Slide 13: HCG – Cluster Wise Revenue Break Up
HCG – Cluster Wise Revenue Break Up Rs in M n C LU ST E R Q2FY26 Q2FY25 Y-O-Y H1FY26 H1FY25 Y-O-Y • Karnataka : 5% growth on account of fall in K A R N ATA K A 1,725 1,639 5.3% 3,367 3,206 5.0% International patient flow due to G UJA R AT 1,746 1,577 10.7% 3,442 3,125 10.2% geopolitical headwinds an
Slide 14: Milann – Operational & Business Update
Milann – Operational & Business Update BENGALURU (5 Centers) Growth Growth Particulars Q2FY26 Q2FY25 H1FY26 H1FY25 Y-o-Y Y-o-Y New Shivananda 1,382 1,437 -3.8% 2,901 2,797 3.7% Indiranagar Registrations Whitefield IVF Cycles 249 348 -28.4% 549 703 -21.9% JP Nagar HSR Emerging Centers Revenues 148 15
Slide 15: Capital Expenditure & Net Debt
Capital Expenditure & Net Debt CAPITAL EXPENDITURE (Rs. Mn.) NET DEBT (Rs. Mn.) HCG CENTERS H1FY25 H1FY26 NET DEBT 30 th Sept 2025 30 th June 2025 Bank Debt (1) 7,732 9,352 Established Centers 1,267 1,240 Vendor Finance (2) 187 180 Other Debt 114 114 Emerging Centers 56 324 Less: Cash & Cash Equival
Slide 16: Q2 & H1 FY26 Consolidated Profit & Loss Account
Q2 & H1 FY26 Consolidated Profit & Loss Account Profit and Loss (in Rs. Mn.) Q2 FY26 Q2 FY25 Y-o-Y H1 FY26 H1 FY25 Y-o-Y Revenues from Operations 6,453 5,525 12,571 10,772 Income from Govt. Grant 17 11 31 20 Total Revenue from Operations 6,470 5,535 16.9% 12,601 10,791 16.8% Cost of Goods Sold 1,773
Slide 17: Consolidated Balance Sheet
Consolidated Balance Sheet Balance Sheet - Equity & Liabilities (in Rs. Mn.) Sep.25 Mar.25 Balance Sheet - Assets (Rs. Mn.) Sep.25 Mar.25 Equity Share Capital 1,410 1,394 Non-Current Assets Other Equity 7,796 7,830 Property, Plant And Equipment 12,494 12,689 Equity Attributable To Equity Holders Of
Slide 18: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement (in Rs. Mn) H1FY26 FY25 Net Profi t Before Ta x 317 570 Adjus tments For: Non - Ca s h Items / Other Inves tment Or Fi na nci a l Items 1,473 3,685 Operating Profit Before Working Capital Changes 1,791 4,254 Cha nges In Worki ng Ca pi tal 252 (765
Slide 19: About Us
CIN: L15200KA1998PLC023489 About Us: HealthCare Global Enterprises Ltd. For updates and specific queries, please visit www.hcgoncology.com or contact: (HCG), headquartered in Bengaluru, is the largest provider of cancer care in India. Through its network of 22 comprehensive cancer centers across Hea
Slide 20: Thank You
THANK YOU www.hcgoncology.com www. h c g o n c o l o g y. c o m
HealthCare Global Enterprises — Q2 & H1 FY26 Earnings Presentation on 6ix